ArticleEuropean heart journal2023

SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world.

Nikolaus Marx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.